DCM
ONC

Driehaus Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Driehaus Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
35,504
-119,498
-77% -$35.2M 0.06% 275
2026
Q1 		$46M Buy
155,002
+131,789
+568% +$42.7M 0.34% 105
2025
Q4 		$7.05M Buy
23,213
+9,852
+74% +$3.22M 0.05% 294
2025
Q3 		$4.55M Sell
13,361
-184,842
-93% -$56.1M 0.03% 327
2025
Q2 		$48M Buy
198,203
+17,247
+10% +$4.23M 0.38% 83
2025
Q1 		$49.3M Buy
180,956
+171,170
+1,749% +$40M 0.47% 63
2024
Q4 		$1.81M Sell
9,786
-1,796
-16% -$367K 0.01% 313
2024
Q3 		$2.6M Buy
11,582
+3,397
+42% +$611K 0.02% 295
2024
Q2 		$1.17M Buy
+8,185
New +$1.26M 0.01% 301
2023
Q3 		– Sell
-3,305
Closed -$589K – 455
2023
Q2 		$589K Sell
3,305
-3,128
-49% -$720K 0.01% 336
2023
Q1 		$1.39M Buy
6,433
+2,057
+47% +$493K 0.02% 324
2022
Q4 		$962K Buy
+4,376
New +$803K 0.01% 302
2022
Q2 		– Sell
-2,977
Closed -$561K – 453
2022
Q1 		$561K Buy
2,977
+959
+48% +$204K 0.01% 338
2021
Q4 		$547K Buy
+2,018
New +$681K 0.01% 322
2021
Q3 		– Sell
-153,442
Closed -$52.7M – 497
2021
Q2 		$52.7M Buy
153,442
+72,623
+90% +$24.1M 0.7% 30
2021
Q1 		$28.1M Buy
+80,819
New +$26.8M 0.42% 68
2020
Q4 		– Sell
-154,666
Closed -$44.3M – 474
2020
Q3 		$44.3M Buy
+154,666
New +$36.4M 0.91% 17

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Driehaus Capital Management's ONC Position: Q2 2026 in Review

Driehaus Capital Management reduced its BeOne Medicines Ltd (ONC) stake by 77% in Q2 2026, selling an estimated $35.2M and leaving 35,504 shares worth $10.1M. The position accounts for 0.06% of the portfolio, ranked #275.

Driehaus Capital Management first reported a position in ONC in Q3 2020 and has held it in 17 quarters since. The position peaked at $52.7M in Q2 2021. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Driehaus Capital Management held 35,504 shares of BeOne Medicines Ltd worth $10.1M as of Q2 2026.
  • Driehaus Capital Management sold 119,498 BeOne Medicines Ltd shares in Q2 2026, an estimated $35.2M.
  • BeOne Medicines Ltd made up 0.06% of Driehaus Capital Management's portfolio in Q2 2026, its #275 holding.
  • Driehaus Capital Management first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 17 quarters since.
  • Driehaus Capital Management's BeOne Medicines Ltd position peaked at $52.7M in Q2 2021.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.